Canada - engelsk - Health Canada

csl behring canada inc - coagulation factor ix (recombinant), albumin fusion protein (rix-fp) - kit - 1000unit - coagulation factor ix (recombinant), albumin fusion protein (rix-fp) 1000unit - hemostatics

Canada - engelsk - Health Canada

csl behring canada inc - coagulation factor ix (recombinant), albumin fusion protein (rix-fp) - kit - 2000unit - coagulation factor ix (recombinant), albumin fusion protein (rix-fp) 2000unit - hemostatics

Canada - engelsk - Health Canada

novo nordisk canada inc - coagulation factor ix (recombinant), pegylated - powder for solution - 500unit - coagulation factor ix (recombinant), pegylated 500unit - hemostatics

Canada - engelsk - Health Canada

novo nordisk canada inc - coagulation factor ix (recombinant), pegylated - powder for solution - 1000unit - coagulation factor ix (recombinant), pegylated 1000unit - hemostatics

Canada - engelsk - Health Canada

novo nordisk canada inc - coagulation factor ix (recombinant), pegylated - powder for solution - 2000unit - coagulation factor ix (recombinant), pegylated 2000unit - hemostatics

Canada - engelsk - Health Canada

csl behring canada inc - coagulation factor ix (recombinant), albumin fusion protein (rix-fp) - kit - 3500unit - coagulation factor ix (recombinant), albumin fusion protein (rix-fp) 3500unit - hemostatics

Israel - engelsk - Ministry of Health

sanofi - aventis israel ltd - coagulation factor ix (recombinant fc fusion protein –rfixfc) - powder and solvent for solution for injection - coagulation factor ix (recombinant fc fusion protein –rfixfc) 1000 iu - coagulation factor ix - alprolix™, coagulation factor ix (recombinant), fc fusion protein, is arecombinant dna derived, coagulation factor ix concentrate indicated inadults and children 12 years of age and older with hemophilia b for:• control and prevention of bleeding episodes,• perioperative management,• routine prophylaxis to prevent or reduce the frequency of bleeding episodes.alprolix™ is not indicated for induction of immune tolerance in patients with hemophilia b.

Israel - engelsk - Ministry of Health

sanofi - aventis israel ltd - coagulation factor ix (recombinant fc fusion protein –rfixfc) - powder and solvent for solution for injection - coagulation factor ix (recombinant fc fusion protein –rfixfc) 2000 iu - coagulation factor ix - alprolix™, coagulation factor ix (recombinant), fc fusion protein, is arecombinant dna derived, coagulation factor ix concentrate indicated inadults and children 12 years of age and older with hemophilia b for:• control and prevention of bleeding episodes,• perioperative management,• routine prophylaxis to prevent or reduce the frequency of bleeding episodes.alprolix™ is not indicated for induction of immune tolerance in patients with hemophilia b..

Israel - engelsk - Ministry of Health

sanofi - aventis israel ltd - coagulation factor ix (recombinant fc fusion protein –rfixfc) - powder and solvent for solution for injection - coagulation factor ix (recombinant fc fusion protein –rfixfc) 3000 iu - coagulation factor ix - alprolix™, coagulation factor ix (recombinant), fc fusion protein, is arecombinant dna derived, coagulation factor ix concentrate indicated inadults and children 12 years of age and older with hemophilia b for:• control and prevention of bleeding episodes,• perioperative management,• routine prophylaxis to prevent or reduce the frequency of bleeding episodes.alprolix™ is not indicated for induction of immune tolerance in patients with hemophilia b.

Israel - engelsk - Ministry of Health

sanofi - aventis israel ltd - coagulation factor ix (recombinant fc fusion protein –rfixfc) - powder and solvent for solution for injection - coagulation factor ix (recombinant fc fusion protein –rfixfc) 500 iu - coagulation factor ix - alprolix™, coagulation factor ix (recombinant), fc fusion protein, is arecombinant dna derived, coagulation factor ix concentrate indicated inadults and children 12 years of age and older with hemophilia b for:• control and prevention of bleeding episodes,• perioperative management,• routine prophylaxis to prevent or reduce the frequency of bleeding episodes.alprolix™ is not indicated for induction of immune tolerance in patients with hemophilia b..